Oculus Receives FDA Clearance for the Myopia Master
08/10/2021
Oculus announced that it has received FDA 510(k) clearance for the Myopia Master, which combines axial length, refraction values, and the central corneal radii measurements.
The quick, contactless measurement method for axial length is not influenced by the accommodation status of the eye and delivers reproducible results, according to Oculus. The Myopia Master integrates the approved axial length measurement function from the Pentacam AXL.
The new Myopia Master saves space and can be mounted on a workstation or an ophthalmic table. The software is operated directly via the inbuilt display.